{
    "SPADE_N_14042": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14042",
            "Peptide Name": "RNase 6 R66Q Polymorphism (Ribonuclease 6; Ribonuclease family, antimicrobial protein; natural AMPs; human; primates, mammals, animals; UCSS1a; 4S=S)",
            "Source": "urinary tract,Homo sapiens",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "WPKRLTKAHWFEIQHIQPSPLQCNRAMSGINNYTQHCKHQNTFLHDSFQNVAAVCDLLSIVCKNRQHNCHQSSKPVNMTDCRLTSGKYPQCRYSAAAQYKFFIVACDPPQKSDPPYKLVPVHLDSIL",
            "Sequence Length": 127,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram-",
                "bacteria-agglutinating AMPs"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 14624.63,
            "PI": 9.1,
            "Hydrophobicity": -0.54,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Anguita R, Prats-Ejarque G, Moussaoui M, Becknell B, Boix E. 2024",
                    "Reference": "Int J Mol Sci. 2024 Jan 3;25(1):604. doi: 10.3390/ijms25010604.PubMed",
                    "Title": "A Common Polymorphism in RNASE6 Impacts Its Antimicrobial Activity toward Uropathogenic Escherichia coli."
                }
            ],
            "Frequent Amino Acids": "QPS",
            "Absent Amino Acids": "OU",
            "Basic Residues": 22,
            "Acidic Residues": 7,
            "Hydrophobic Residues": 54,
            "Polar Residues": 84,
            "Positive Residues": 22,
            "Negative Residues": 7,
            "Net Charge": 15,
            "Comments": "AMP significance: A common polymorphism in RNASE6 compromises Its antimicrobial activity toward uropathogenic E. coli.Sequence analysis: APD analysis reveals that this sequence is similar (99.21%) toRNase 6L: 36%; K: 36%.Activity: this single-residue variant (MBC75 8.22 uM) is less active against E. coli than the WT (MBC75 2.08 uM). MBC100 > 20 uM against other strains.SAR: This variant also has reduced antibacterial activity (e.g., E. coli), LPS binding and bacteria-agglutinating ability compared to the WT with an arginine at position 66 (MAC 1.38 uM; cf. WT 0.22 uM). MAC=minimal agglutination concentration. In contrast, this change did not harm catalytic activity.Est.Jan2024;",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_11200",
                    "Similarity": 1.0,
                    "Sequence": "WPKRLTKAHWFEIQHIQPSPLQCNRAMSGINNYTQHCKHQNTFLH"
                },
                {
                    "SPADE_ID": "SPADE_UN_30402",
                    "Similarity": 1.0,
                    "Sequence": "WPKRLTKAHWFEIQHIQPSPLQCNRAMSGINNYTQHCKHQNTFLH"
                },
                {
                    "SPADE_ID": "SPADE_N_13542",
                    "Similarity": 0.9921259842519685,
                    "Sequence": "WPKRLTKAHWFEIQHIQPSPLQCNRAMSGINNYTQHCKHQNTFLHDSFQNVAAVCDLLSIVCKNRRHNCHQSSKPVNMTDCRLTSGKYPQCRYSAAAQYKFFIVACDPPQKSDPPYKLVPVHLDSIL"
                }
            ]
        }
    }
}